Early Changes of VEGF Levels After Zoledronic Acid in Women With Postmenopausal Osteoporosis: A Potential Role of Vitamin D
Zoledronic acid (Zol) is a widely used intravenous aminobisphosphonate to treat both benign and malignant skeletal diseases, and bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a serious side effect whose pathophysiology remains poorly understood. Vascular Endothelial Growth Factor (VEGF)...
मुख्य लेखकों: | , , , , , , |
---|---|
स्वरूप: | लेख |
भाषा: | English |
प्रकाशित: |
Frontiers Media S.A.
2021-11-01
|
श्रृंखला: | Frontiers in Medicine |
विषय: | |
ऑनलाइन पहुंच: | https://www.frontiersin.org/articles/10.3389/fmed.2021.748438/full |